Pharma4ever QA ApS: Financial statements 2020
CVR: 39104644
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Pharma4ever QA ApS (CVR 39104644) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 6,046,399 and a net result of DKK 1,589,092 compared with DKK 1,120,589 the year before. That is an increase of 23.2% compared with the year before. Equity in the 2020 report amounted to DKK 1,678,698. The solvency ratio was 44.3%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 6,046,399
- Profit/Loss
- DKK 1,589,092
- Equity
- DKK 1,678,698
- Total Assets
- DKK 3,788,571
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 6 mio. | 1.6 mio. | 1.7 mio. | 5 |
| 2019 | - | 4.9 mio. | 1.1 mio. | 1.2 mio. | 4 |
How creditworthy is Pharma4ever QA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Pharma4ever QA ApS has published its annual report for 2019. Gross profit came to DKK 4,906,456, and the net result was DKK 1,120,589.
About Pharma4ever QA ApS
Pharma4ever QA ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2017. The company is under bankruptcy. The company is registered under the industry Anden teknisk rådgivning. The company is owned by BHP Holding ApS, Andresen Holding af 29. maj 2015 ApS and SLP Holding 2017 ApS. The company has 3 employees (2018). In 2024, the company reported a gross profit of DKK 11,494,444 and a net result of DKK 2,507,255 compared with DKK 1,727,927 the year before. Equity in the 2024 report amounted to DKK 2,557,256.